Free Trial
NASDAQ:IFRX

InflaRx (IFRX) Stock Price, News & Analysis

InflaRx logo
$0.86 +0.04 (+4.70%)
As of 02:23 PM Eastern

About InflaRx Stock (NASDAQ:IFRX)

Key Stats

Today's Range
$0.82
$0.89
50-Day Range
$0.73
$1.85
52-Week Range
$0.71
$2.82
Volume
347,727 shs
Average Volume
293,462 shs
Market Capitalization
$57.63 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.60
Consensus Rating
Buy

Company Overview

InflaRx Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

IFRX MarketRank™: 

InflaRx scored higher than 54% of companies evaluated by MarketBeat, and ranked 476th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    InflaRx has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    InflaRx has only been the subject of 3 research reports in the past 90 days.

  • Read more about InflaRx's stock forecast and price target.
  • Earnings Growth

    Earnings for InflaRx are expected to decrease in the coming year, from ($1.04) to ($1.16) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of InflaRx is -1.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of InflaRx is -1.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    InflaRx has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about InflaRx's valuation and earnings.
  • Percentage of Shares Shorted

    2.10% of the float of InflaRx has been sold short.
  • Short Interest Ratio / Days to Cover

    InflaRx has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InflaRx has recently decreased by 7.09%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    InflaRx does not currently pay a dividend.

  • Dividend Growth

    InflaRx does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.10% of the float of InflaRx has been sold short.
  • Short Interest Ratio / Days to Cover

    InflaRx has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in InflaRx has recently decreased by 7.09%, indicating that investor sentiment is improving significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for InflaRx this week, compared to 2 articles on an average week.
  • Search Interest

    Only 2 people have searched for IFRX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added InflaRx to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, InflaRx insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    16.30% of the stock of InflaRx is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    42.39% of the stock of InflaRx is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about InflaRx's insider trading history.
Receive IFRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InflaRx and its competitors with MarketBeat's FREE daily newsletter.

IFRX Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

IFRX Stock Analysis - Frequently Asked Questions

InflaRx's stock was trading at $2.47 on January 1st, 2025. Since then, IFRX stock has decreased by 65.2% and is now trading at $0.8585.

InflaRx N.V. (NASDAQ:IFRX) announced its earnings results on Wednesday, May, 7th. The company reported ($0.14) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.04. The firm had revenue of $0.03 million for the quarter, compared to analysts' expectations of $0.03 million.

InflaRx (IFRX) raised $100 million in an IPO on Wednesday, November 8th 2017. The company issued 6,700,000 shares at $14.00-$16.00 per share. J.P. Morgan, Leerink Partners and BMO Capital Markets acted as the underwriters for the IPO.

Shares of IFRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InflaRx investors own include G1 Therapeutics (GTHX), Xeris Biopharma (XERS), Bristol Myers Squibb (BMY), Enterprise Products Partners (EPD), Exelixis (EXEL), Tesla (TSLA) and Alibaba Group (BABA).

Company Calendar

Last Earnings
5/07/2025
Today
7/08/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IFRX
Employees
60
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$6.60
High Stock Price Target
$10.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+686.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.85 million
Pretax Margin
-33,646.85%

Debt

Sales & Book Value

Annual Sales
$180 thousand
Price / Cash Flow
N/A
Book Value
$1.13 per share
Price / Book
0.74

Miscellaneous

Free Float
56,190,000
Market Cap
$56.32 million
Optionable
Optionable
Beta
1.29
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:IFRX) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners